From July 1, 2023 to September 30, 2023, the company has repurchased 861,800 shares, representing 2.36% for ¥2,762.72 million. With this, the company has completed the repurchase of 910,200 shares, representing 2.49% for ¥2,927.18 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,110 JPY | +1.97% | +2.64% | -4.89% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.89% | 691M | |
+47.54% | 765B | |
-6.82% | 354B | |
+19.36% | 331B | |
+8.45% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+4.67% | 164B | |
-2.40% | 162B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.